Primary glomerular disease associated with high cardiovascular disease risk

Published On 2022-06-06 04:30 GMT | Update On 2022-06-07 10:08 GMT

It is a known fact that patients with chronic kidney disease are known to be at high risk of cardiovascular disease. Cardiovascular risk in patients with primary glomerular diseases is poorly understood because these conditions are rare and require a kidney biopsy for diagnosis.

Very little is known about the risk of cardiovascular disease (CVD) in such patients. Hence, in a population-based study on adults with primary glomerular disease, researchers described the risk of cardiovascular disease compared to the general population and also studied the impact of traditional and kidney-related risk factors on cardiovascular disease risk.

Study is published in the American Journal of Kidney Diseases (AJKD). Here the rate of cardiovascular events in 1,912 Canadian patients with biopsy-proven IgA nephropathy, minimal change disease, and membranous nephropathy was 2.5 times as high as the general population and was high for each disease type.

Consideration of disease type, kidney function, and proteinuria improved the prediction of cardiovascular events. Therefore, to summarise, this population-level study showed that patients with primary glomerular diseases have a high cardiovascular risk, and that inclusion of kidney-specific risk factors may improve risk stratification.

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Primary glomerular disease associated with high cardiovascular disease risk

Similar News

Want to Keep Your Brain Young? Researchers Say This Diet Works

AI Model May Accurately Predict Kidney Failure Risk in Chronic Kidney Disease Patients: Study Shows

Journal Club- Infection Patterns and Survival Among Renal Transplant Recipients

Alarming Growth in Antifungal Resistance Tracked Over 30 Years in Dutch Study

COVID-19 Vaccination Reduces Dialysis and Mortality Risk in Acute Kidney Injury Patients: Study

Study Reveals Why Your Immune System Works Better in Daylight

World's First Human Bladder Transplant Successfully Performed by USC and UCLA Surgeons

Trial Shows Tirzepatide May Benefit People with Obesity, Kidney Disease and Heart Failure